Wednesday, January 13, 2016

Longstanding academic integrity campaigner David Vaux says the “big breakthrough” in 20th century medical research — double blind clinical trials, where neither patients nor clinicians know who gets the drug and who gets the placebo — should be extended to peer review. “The reason for the low quality in publications is that reviewers and editors know who the authors are,” Professor Vaux said.
Post a Comment